<DOC>
	<DOCNO>NCT01809054</DOCNO>
	<brief_summary>This prospective , randomized study pre-surgery 6 week post-surgery design detect change coagulability follow elective total knee hip arthroplasty . Patients randomize one two standard prophylaxis treatment use Sinai Hospital : 1 . Arixtra ( 2.5 mg SQ/QD ) subcutaneous injection daily 2 week follow aspirin 325 mg 5 week , 2 . Pneumatic compression stocking ( MCS , Active Care , medical compression system Inc. , Israel ) 2 week concomitant Aspirin 325 mg daily 5 week .</brief_summary>
	<brief_title>Pilot Study Evaluating Alterations Thrombogenicity Platelet Reactivity Following Lower Extremity Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<criteria>1 . Men woman age â‰¥ 18 year old 2 . Total knee total hip arthroplasty plan 60 day follow study enrollment 1 . Preexisting anticoagulant therapy ( Heparin , Lovenox , Arixtra , Warfarin , Xarelto , nonmentioned anticoagulant ) admission 2 . History bleed diathesis 3 . Known active malignancy 4 . Prothrombin time &gt; 1.5 x control 5 . Platelet count &lt; 100,000/mm3 , hematocrit &lt; 30 % , creatinine clearance &lt; 30 mL/min 6 . Immunosuppression , e.g. , human immunodeficiency virus ( HIV ) infection , Chronic hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) infection , Bacterial endocarditis 7 . Major surgery within past 3 month enrollment 8 . Patients require bilateral arthroplasty 9 . Body weight &lt; 50 kg ( venous thromboembolism prophylaxis ) 10 . Unable return site followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Hip , Knee , Arthroplasty , venous thromboembolic event , blood loss</keyword>
</DOC>